difference between tirzepatide and semaglutide vs Semaglutide: Weight Loss, Side Effects, Uses What's the Difference Between Semaglutide

GLP-1 RECEPTOR AGONISTS IN DKD Mechanisms of action GLP-1 receptor agonists lower blood glucose levels primarily by stimulating insulin and somatostatin secretion and suppressing glucagon release from pancreatic islets, thereby improving glycemic control [61]

It was discovered in 2012,[3] by a team of researchers at Novo Nordisk as a longer-acting alternative to liraglutide.[4] Clinical trials were started in 2015, and phase 3 was completed in 2016.[5] Researchers at the University of Leeds and Novo Nordisk reported in 2017 that it can also be used for the treatment of obesity.[6] It reduces hunger, food craving and body fat.[7] FDA approval was applied in December 2016, and in October 2017 FDA Advisory Committee voted 16-0 in favour.[8] On December 5, 2017, semaglutide was approved by the US FDA

Its where I feel most comfortable: advocating for my clients, arguing their cases

Additionally, decreased production of ceramides may potentially harm gut epithelial cells by reducing LPS hydrolysis and increase gut permeability [28]